Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Egile Nagusiak: | , , , , , , , , , , , , , , , , |
---|---|
Formatua: | Conference item |
Argitaratua: |
Oxford University Press
2016
|
Gaia: |
---|